What does DR. PHILIPPE BORREMAN do?

DR. PHILIPPE BORREMAN is a specialist medical practice in Kortenaken. Private Limited, started on 27 December 2017, 2 establishments.

What is the address of DR. PHILIPPE BORREMAN?

The registered office of DR. PHILIPPE BORREMAN is located at Gelbergenstraat 15, 3471 Kortenaken.

Is DR. PHILIPPE BORREMAN still active?

Yes. According to the CBE (29 October 2026) DR. PHILIPPE BORREMAN is active, legal situation “Normale toestand”, started on 27 December 2017.

Is DR. PHILIPPE BORREMAN registered on Peppol?

Yes, DR. PHILIPPE BORREMAN is registered on the Peppol network with ID 0208:0686855812.

What is the enterprise number of DR. PHILIPPE BORREMAN?

The enterprise number of DR. PHILIPPE BORREMAN is BE0686855812.

When was DR. PHILIPPE BORREMAN founded?

DR. PHILIPPE BORREMAN was founded on 27 December 2017.

Who are the directors of DR. PHILIPPE BORREMAN?

According to the 2025 annual accounts, the directors of DR. PHILIPPE BORREMAN are: Philippe Borreman.

Is DR. PHILIPPE BORREMAN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 December 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR. PHILIPPE BORREMAN make in 2025?

DR. PHILIPPE BORREMAN posted a profit after taxes of € 153,417 in financial year 2025.

What is the revenue of DR. PHILIPPE BORREMAN?

As a small company, DR. PHILIPPE BORREMAN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 234,956.

DR. PHILIPPE BORREMAN (Private Limited) - Kortenaken

Dossier DR. PHILIPPE BORREMAN, printed on 29 October 2026 from databakkes.be/en/0686855812/dr-philippe-borreman. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. PHILIPPE BORREMAN from Kortenaken, company number BE0686855812, closed financial year 2025 with a result of € 153,417 after tax. For that financial year DR. PHILIPPE BORREMAN recorded a gross margin of € 234,956 and equity of € 172,986. Compared with financial year 2024, the result moved from € 210,809 to € 153,417. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 4, 2026.

What it is worth Growing

€ 172,986

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 153,417

▼ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 106,925

▲ 75% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 130,000 paid out

85 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 4,191

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 455

▲ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,750

▼ 90% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 234,629 Gross margin 2022: € 234,629 First fiscal year in the series	€ 194,629 Gross margin 2023: € 194,629 ▼ 17% vs 2022 (€ 234,629) Unfavourable step	€ 239,275 Gross margin 2024: € 239,275 ▲ 23% vs 2023 (€ 194,629) Favourable step	€ 234,956 Gross margin 2025: € 234,956 ▼ 2% vs 2024 (€ 239,275) Unfavourable step	▼ 2%
Profit after taxes	€ 188,593 Profit after taxes 2022: € 188,593 First fiscal year in the series	€ 153,300 Profit after taxes 2023: € 153,300 ▼ 19% vs 2022 (€ 188,593) Unfavourable step	€ 210,809 Profit after taxes 2024: € 210,809 ▲ 38% vs 2023 (€ 153,300) Favourable step	€ 153,417 Profit after taxes 2025: € 153,417 ▼ 27% vs 2024 (€ 210,809) Unfavourable step	▼ 27%
Equity	€ 200,460 Equity 2022: € 200,460 First fiscal year in the series	€ 153,760 Equity 2023: € 153,760 ▼ 23% vs 2022 (€ 200,460) Unfavourable step	€ 149,569 Equity 2024: € 149,569 ▼ 3% vs 2023 (€ 153,760) Unfavourable step	€ 172,986 Equity 2025: € 172,986 ▲ 16% vs 2024 (€ 149,569) Favourable step	▲ 16%
Total debts	€ 237,142 Total debts 2022: € 237,142 First fiscal year in the series	€ 312,186 Total debts 2023: € 312,186 ▲ 32% vs 2022 (€ 237,142) Unfavourable step	€ 223,187 Total debts 2024: € 223,187 ▼ 29% vs 2023 (€ 312,186) Favourable step	€ 67,759 Total debts 2025: € 67,759 ▼ 70% vs 2024 (€ 223,187) Favourable step	▼ 70%
Cash	€ 210,334 Cash 2022: € 210,334 First fiscal year in the series	€ 24,107 Cash 2023: € 24,107 ▼ 89% vs 2022 (€ 210,334) Unfavourable step	€ 61,125 Cash 2024: € 61,125 ▲ 154% vs 2023 (€ 24,107) Favourable step	€ 106,925 Cash 2025: € 106,925 ▲ 75% vs 2024 (€ 61,125) Favourable step	▲ 75%
Retained profit	€ 181,860 Retained profit 2022: € 181,860 First fiscal year in the series	€ 135,160 Retained profit 2023: € 135,160 ▼ 26% vs 2022 (€ 181,860) Unfavourable step	€ 130,969 Retained profit 2024: € 130,969 ▼ 3% vs 2023 (€ 135,160) Unfavourable step	€ 154,386 Retained profit 2025: € 154,386 ▲ 18% vs 2024 (€ 130,969) Favourable step	▲ 18%
Dividend	€ 222,477 Dividend 2022: € 222,477 First fiscal year in the series	€ 200,000 Dividend 2023: € 200,000 ▼ 10% vs 2022 (€ 222,477) Unchanged	€ 215,000 Dividend 2024: € 215,000 ▲ 8% vs 2023 (€ 200,000) Unchanged	€ 130,000 Dividend 2025: € 130,000 ▼ 40% vs 2024 (€ 215,000) Unchanged	▼ 40%
Bank debt	€ 69 Bank debt 2022: € 69 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 69) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 437,602 Balance sheet total 2022: € 437,602 First fiscal year in the series	€ 465,946 Balance sheet total 2023: € 465,946 ▲ 6% vs 2022 (€ 437,602) Unchanged	€ 372,755 Balance sheet total 2024: € 372,755 ▼ 20% vs 2023 (€ 465,946) Unchanged	€ 240,745 Balance sheet total 2025: € 240,745 ▼ 35% vs 2024 (€ 372,755) Unchanged	▼ 35%

Key figures of DR. PHILIPPE BORREMAN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. PHILIPPE BORREMAN?

What happened at DR. PHILIPPE BORREMAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 4, 2026 New annual accounts for financial year 2025: profit of € 153,417 (▼ 27% vs 2024). filed late Source: NBB ↗
Dec 27, 2017 New establishment in Tienen. KBO
Dec 27, 2017 New establishment in Aarschot. KBO
Dec 27, 2017 Start of the company according to the CBE. KBO

In short

From € 188,593 profit in 2022 to € 153,417 profit in 2025.

Paid € 209,938 in corporate taxes since 2022.

Best year ever: 2024, with € 210,809 profit.

Paid out € 767,477 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Philippe Borreman

DR. PHILIPPE BORREMAN

Behind DR. PHILIPPE BORREMAN is Philippe Borreman.

Directors

According to the 2025 annual accounts

Philippe Borreman

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Gelbergenstraat 15

3471 Kortenaken

2.272.522.037

Kliniekstraat 45

3300 Tienen

Active since 27 December 2017

2.272.522.136

Langdorpsesteenweg 129

3200 Aarschot

Active since 27 December 2017

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0686.855.812
VAT number: BE 0686.855.812
Registered office: Gelbergenstraat 15, 3471 Kortenaken
Names & denominations: DR. PHILIPPE BORREMAN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 December 2017
Peppol: Active · Active since 15 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗